- Supported exchanges /
- TW /
- 6541.TW
Tanvex BioPharma Inc (6541 TW) stock market data APIs
Tanvex BioPharma, Inc., a biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States. It focuses on delivering biosimilars which target neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis. The company's products pipeline includes TX01 and TX-05 which have completed Phase III clinical trials; TX-04 and TX-16 that are in Phase I clinical trial; and TX-52 and other products which are in pre-clinical trial. The company was formerly known as Ruenvex Biotech, Inc. Tanvex BioPharma, Inc. was incorporated in 2013 and is based in George Town, the Cayman Islands.
Tanvex BioPharma Inc Financial Data Overview
| 68.1 | |
| 68.9 | |
| - | |
| 69.8 | |
| 67.6 | |
| 35.05-80 | |
| 11 452 M | |
| 164 M | |
| 34 557 K | |
| 0.447 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Tanvex BioPharma Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 34 557 K
- EBITDA -1 673 732 992
- Earnings Per Share -10.94
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Tanvex BioPharma Inc Earnings via APIs
- Latest Release 2024-11-08
- EPS/Forecast NaN
Get Tanvex BioPharma Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
